Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase 2, Open-Label, Multi-Center Study of Venetoclax in Combination with Carfilzomiib and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma


Collapse Overview 
Collapse sponsor award id
M15


Collapse Biography 

Collapse Time 
Collapse start date
2017-05-30